Holen Sie sich die Stockscreener-App
126.36
2.83%
3.48
Handel nachbörslich:
126.50
0.14
+0.11%
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action InvestigationWGS - Eastern Progress
WGS Investor News: If You Have Suffered Losses in GeneDx - GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are - Bluefield Daily Telegraph
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
GeneDx Holdings Corp. Stock Lags Behind Sector BenchmarksJuly 2025 Setups & Daily Profit Maximizing Trade Tips - sundaytimes.kr
GeneDx Holdings Corp. Securities Class Action Investigation - AInvest
GeneDx Holdings stock hits 52-week high at 118.47 USD By Investing.com - Investing.com South Africa
GeneDx Holdings stock hits 52-week high at 118.47 USD - Investing.com
GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action InvestigationWGS - ACCESS Newswire
GeneDx at Canaccord Conference: Expanding Genomic Horizons By Investing.com - Investing.com Nigeria
GeneDx at Canaccord Conference: Expanding Genomic Horizons - Investing.com
How Investors May Respond To GeneDx Holdings (WGS) Raising 2024 Revenue Guidance After Swing to Profit - simplywall.st
GeneDx Holdings Corp. (WGS) Sees Solid Earnings Growth Amid Rising Estimates - AInvest
Will GENEDX HOLDINGS (WGS) Gain on Rising Earnings Estimates? - Yahoo Finance
Genedx Holdings Corp. shares rise 1.90% after-hours as Rosen Law Firm investigates potential securities claims. - AInvest
Should You Buy GeneDx Holdings Corp. (WGS) After Golden Cross? - Zacks Investment Research
Industry Analysts Just Upgraded Their GeneDx Holdings Corp. (NASDAQ:WGS) Revenue Forecasts By 11% - 富途牛牛
GeneDx Holdings' (NASDAQ:WGS) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
William Blair Investment Management, LLC's Strategic Acquisition in GeneDx Holdings Corp - GuruFocus
GeneDx investigated for misleading statements and practices. - AInvest
Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS) - GlobeNewswire
GeneDx Leadership to Present at 3 Premier Healthcare Conferences: Morgan Stanley, Wells Fargo, Canaccord - Stock Titan
GeneDx to Participate in Upcoming Investor Conferences - Business Wire
Piper Sandler reiterates Overweight rating on GeneDx stock, citing multiyear growth potential - Investing.com Canada
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - ADVFN Brasil
How does GeneDx Holdings Corp. generate profit in a changing economyCapitalize on market momentum for big wins - Jammu Links News
What catalysts could drive GeneDx Holdings Corp. stock higher in 2025Maximize gains with expert analysis - Jammu Links News
Published on: 2025-08-04 06:03:13 - Jammu Links News
Is GeneDx Holdings Corp. stock overvalued or undervaluedHigh-margin investment plays - Jammu Links News
Published on: 2025-08-04 04:10:50 - Jammu Links News
What are analysts’ price targets for GeneDx Holdings Corp. Equity Warrant in the next 12 monthsTremendous gains - Jammu Links News
How many analysts rate GeneDx Holdings Corp. Equity Warrant as a “Buy”Discover high-growth stocks for your portfolio - Jammu Links News
Should I hold or sell GeneDx Holdings Corp. Equity Warrant stock in 2025Achieve rapid capital gains with smart investing - Jammu Links News
How volatile is GeneDx Holdings Corp. stock compared to the marketInvest with confidence backed by data - Jammu Links News
Is GeneDx Holdings Corp. Equity Warrant stock overvalued or undervaluedBuild a diversified portfolio for risk mitigation - Jammu Links News
How strong is GeneDx Holdings Corp. company’s balance sheetGet timely market insights for better trades - Jammu Links News
What institutional investors are buying GeneDx Holdings Corp. stockFree Daily Trading Room Entry - Jammu Links News
How strong is GeneDx Holdings Corp. Equity Warrant company’s balance sheetBuild your wealth with consistent stock growth - Jammu Links News
When is GeneDx Holdings Corp. Equity Warrant stock expected to show significant growthAchieve rapid returns with smart investment plans - Jammu Links News
What analysts say about GeneDx Holdings Corp. Equity Warrant stockSignificant capital appreciation - Jammu Links News
Is it the right time to buy GeneDx Holdings Corp. Equity Warrant stockUnlock daily market insights for better trades - Jammu Links News
Published on: 2025-08-03 12:13:18 - Jammu Links News
Why is GeneDx Holdings Corp. Equity Warrant stock attracting strong analyst attentionStrong return on assets - Jammu Links News
What are GeneDx Holdings Corp. Equity Warrant company’s key revenue driversOutstanding trading profits - Jammu Links News
0.67%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):